BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 22614965)

  • 21. Adjuvant chemotherapy for resected non-small cell lung cancer.
    Wakelee H; Chhatwani L
    Semin Thorac Cardiovasc Surg; 2008; 20(3):198-203. PubMed ID: 19038728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Early stages of non small cell lung cancer (I. II. IIIA). Postoperative treatments for resected non small-cell lung cancer].
    Barlési F
    Rev Mal Respir; 2006 Nov; 23(5 Pt 3):16S47-16S53. PubMed ID: 17268336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjuvant chemotherapy in resected non-small cell lung cancer.
    Cangiano R
    Rays; 2004; 29(4):435-7. PubMed ID: 15852732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvant therapy of lung cancer.
    Joss RA; Brand B
    Helv Chir Acta; 1990 Jan; 56(5):735-47. PubMed ID: 2157687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Is preoperative chemotherapy in locally advanced non-small-cell bronchial carcinoma of value?].
    Betticher DC; von Briel C; Gugger M; Cerny T; Ris HB
    Ther Umsch; 1998 Jul; 55(7):399-401. PubMed ID: 9702102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [New trends in adjuvant chemotherapy for non-small-cell lung cancer].
    Dediu M; Alexandru A; Median D; Vremeş G
    Pneumologia; 2005; 54(2):89-93. PubMed ID: 16536008
    [No Abstract]   [Full Text] [Related]  

  • 27. Current status of adjuvant chemotherapy for stage IB non-small-cell lung cancer: implications for the New Intergroup Trial.
    Wakelee HA; Schiller JH; Gandara DR
    Clin Lung Cancer; 2006 Jul; 8(1):18-21. PubMed ID: 16870041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The future of adjuvant chemotherapy for resected non-small cell lung cancer.
    Vansteenkiste JF; Schildermans RH
    Expert Rev Anticancer Ther; 2005 Feb; 5(1):165-75. PubMed ID: 15757448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Early-stage NSCLC. Resectable non-small cell lung cancers: (neo) adjuvant chemotherapy].
    Berghmans T
    Rev Mal Respir; 2008 Oct; 25(8 Pt 2):3S72-8. PubMed ID: 18971829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant therapy in non-small cell lung cancer: future treatment prospects and paradigms.
    Carbone DP; Felip E
    Clin Lung Cancer; 2011 Sep; 12(5):261-71. PubMed ID: 21831720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Neoadjuvant chemotherapy in non small cell lung cancer].
    Besse B; Vignot S; Le Chevalier T
    Bull Cancer; 2006 Nov; 93(11):1087-92. PubMed ID: 17145577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction therapy before surgery for non-small cell lung cancer.
    Ferraldeschi R; D'Auria G; Ceratti Ade P; Assalone P; Mentuccia L; Ciprotti M; Evangelista ML; Mazzoli M; Di Fonzo C; Cortesi E
    Rays; 2004; 29(4):445-52. PubMed ID: 15852734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of adjuvant chemotherapy in NSCLC (stages I to III).
    Coleman MH; Bueno R
    Surg Oncol Clin N Am; 2011 Oct; 20(4):757-67. PubMed ID: 21986270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HER2/neu expression and amplification in non-small cell lung cancer prior to and after neoadjuvant therapy.
    Junker K; Stachetzki U; Rademacher D; Linder A; Macha HN; Heinecke A; Müller KM; Thomas M
    Lung Cancer; 2005 Apr; 48(1):59-67. PubMed ID: 15777971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Current status of adjuvant chemotherapy for the resected non-small cell lung cancer].
    Tsuboi M; Kato H
    Nihon Rinsho; 2002 May; 60 Suppl 5():329-34. PubMed ID: 12101682
    [No Abstract]   [Full Text] [Related]  

  • 36. [Efficacy of postoperative adjuvant therapy for resected non-small cell lung cancer--an evidence-based review].
    Tanaka F; Wada H
    Gan To Kagaku Ryoho; 2006 Mar; 33(3):300-6. PubMed ID: 16531708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular predictors of response to chemotherapy in non-small cell lung cancer.
    Andrews J; Yeh P; Pao W; Horn L
    Cancer J; 2011; 17(2):104-13. PubMed ID: 21427554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Adjuvant chemotherapy for resectable non-small cell lung cancer (NSCLC)].
    Nakajima E; Katou H
    Kyobu Geka; 2008 Jan; 61(1):4-8. PubMed ID: 18186265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic and predictive markers of benefit from adjuvant chemotherapy in early-stage non-small cell lung cancer.
    Custodio AB; González-Larriba JL; Bobokova J; Calles A; Alvarez R; Cuadrado E; Manzano A; Díaz-Rubio E
    J Thorac Oncol; 2009 Jul; 4(7):891-910. PubMed ID: 19433989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The ALPI Trial: the Italian/European experience with adjuvant chemotherapy in resectable non-small lung cancer.
    Scagliotti GV
    Clin Cancer Res; 2005 Jul; 11(13 Pt 2):5011s-5016s. PubMed ID: 16000605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.